Literature DB >> 7921053

Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. Prepared by the BCSH Blood Transfusion Task Force.

.   

Abstract

There are no current U.K. or international guidelines or regulations covering the production, processing and storage of haemopoietic cells such as to allow their engraftment following myeloablative therapy. This paper seeks to provide such guidelines. It enumerates how quality control and assurance can be applied to this area of transfusion medicine; procedural steps relating to bone marrow harvest on peripheral blood stem cell collection are outlined and recommended doses of nucleated cells suggested for both procedures. General specifications for identification, storage and transportation of bone marrow and peripheral blood stem cells are included and specific laboratory procedures related to the provision of haemopoietic cells for engraftment are outlined. Umbilical cord blood transplants and long-term bone marrow culture are alluded to but these are still in a research phase.

Entities:  

Mesh:

Year:  1994        PMID: 7921053

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  3 in total

1.  Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation.

Authors:  Giuseppe Aprili; Alberto Bosi; Letizia Lombardini; Simonetta Pupella; Aurora Vassanelli
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

Review 2.  Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.

Authors:  G Marcoullis; J Mehta; J Treleaven
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

3.  Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.

Authors:  Hillard M Lazarus; Fangyu Kan; Sergey Tarima; Richard E Champlin; Dennis L Confer; Noelle Frey; Adrian P Gee; John E Wagner; Mary M Horowitz; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2009-05       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.